Stephen Fowler Flatt - 05 Mar 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt by Kristina R. Hulsey, POA
Issuer symbol
NHC
Transactions as of
05 Mar 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2025, 18:17:32 UTC
Previous filing
26 Feb 2025
Next filing
30 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Award $0 +2,914 +5.3% $0.000000 57,579 05 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NHC Option to Purchase Common Stock 4,734 05 Mar 2025 Common Stock 4,734 $63.96 Direct
holding NHC Option to Purchase Common Stock 10,000 05 Mar 2025 Common Stock 10,000 $53.94 Direct
holding NHC Option to Purchase Common Stock 15,000 05 Mar 2025 Common Stock 15,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 18,000 05 Mar 2025 Common Stock 18,000 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.